Designing chitosan-dextran sulfate nanoparticles using charge ratios

AAPS PharmSciTech
Yan ChenHeather Ae Benson

Abstract

The purpose of this study was to examine the effect of charge ratio on the formation and properties of the chitosan (CS)-dextran sulfate (DS) nanoparticles developed for the delivery of water-soluble small and large molecules, including proteins. Rhodamine 6G (R6G) and bovine serum albumin (BSA) were chosen as model molecules. CS-DS nanoparticles were formulated by a complex coacervation process under mild conditions. The influence of formulation and process variables, including the charge ratio of the 2 ionic polymers, on particle size, zeta potential, and nanoparticle entrapment of R6G and BSA was studied. The in vitro release of R6G and BSA was also evaluated, and the integrity of BSA in the release fraction was assessed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Depending on the concentration and charge ratio of DS and CS, nanoparticles with varied size (>or=244 nm) and zeta potential (-47.1-60 mV) were obtained. High entrapment efficiency (98%) was achieved for both R6G and BSA when the charge ratio of the 2 ionic polymers was greater than 1.12. The release of both R6G and BSA from nanoparticles was based on the ion-exchange mechanism. BSA showed much slower continuous release for up to 7 days while s...Continue Reading

References

Dec 20, 1999·Pharmaceutical Research·R Fernández-UrrusunoM J Alonso
Aug 23, 2001·Advanced Drug Delivery Reviews·L IllumS S Davis
Jul 13, 2002·Journal of Pharmaceutical Sciences·Zengshuan MaLee-Yong Lim
Dec 14, 2002·International Journal of Pharmaceutics·Yongmei Xu, Yumin Du
Apr 4, 2003·International Journal of Pharmaceutics·Waree TiyaboonchaiC Russell Middaugh
Apr 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sinjan De, Dennis Robinson
Jul 30, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Waree TiyaboonchaiC Russell Middaugh
Oct 3, 2003·International Journal of Pharmaceutics·E S K TangL Y Lim
Apr 10, 2004·International Journal of Pharmaceutics·V R SinhaS Dhawan
Oct 20, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sunil A AgnihotriTejraj M Aminabhavi
Jul 14, 2005·Journal of Nanoscience and Nanotechnology·Jiaofeng PengShasheng Huang

❮ Previous
Next ❯

Citations

Jan 30, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Wanachat ChaiyasanWaree Tiyaboonchai
Mar 9, 2010·Journal of Biological Engineering·Youngnam ChoRichard Ben Borgens
Nov 5, 2010·Chemical & Pharmaceutical Bulletin·Kalpana NagpalDina Nath Mishra
Jul 3, 2013·Pharmacology & Therapeutics·Andrew J Thorley, Teresa D Tetley
Sep 30, 2014·Carbohydrate Polymers·Sindhuja Bala SubramanianThiyagarajan Devasena
Sep 29, 2011·Journal of Pharmaceutical Sciences·Sameer SharmaYan Chen
Jan 26, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Sreejith RaveendranD Sakthi Kumar
Oct 12, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A CadeteL M D Gonçalves
Mar 15, 2011·International Journal of Pharmaceutics·Susan M AlexChandra P Sharma
Dec 9, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Thierry Delair
Mar 11, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Jin-Kyu ParkYasuko Iwakiri
Feb 11, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Vassilis BourganisCostas Kiparissides
Nov 7, 2013·International Journal of Biomaterials·Haliza KatasKai Leong Lam
Jan 21, 2014·Colloids and Surfaces. B, Biointerfaces·Michael J HeslingaOmolola Eniola-Adefeso
Apr 25, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anita UmerskaLidia Tajber
Jan 15, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Neda HabibiCarmelina Ruggiero
Aug 30, 2011·Journal of Colloid and Interface Science·Sílvia CoelhoSandra Rocha
Oct 30, 2015·Human Vaccines & Immunotherapeutics·Mojgan Allahyari, Elham Mohit
Jan 1, 2011·ISRN Pharmaceutics·Haliza Katas, Chan Mui Wen
Feb 26, 2018·Polymers·Javier Pérez QuiñonesCarlos Peniche
Jun 15, 2013·Physical Chemistry Chemical Physics : PCCP·Diana PaivaSandra Rocha
Nov 22, 2017·Pharmaceutics·Munawar A MohammedEllen K Wasan
May 20, 2020·Frontiers in Bioengineering and Biotechnology·Tiziana FischettiWojciech Swieszkowski
Nov 19, 2019·Current Pharmaceutical Biotechnology·Avishan ShabaniHaleh Bakhshandeh
Jun 18, 2019·Theriogenology·Jean M FeugangPeter L Ryan
May 11, 2021·International Journal of Biological Macromolecules·Farzad SeidiMasoud Mozafari
Oct 15, 2020·Carbohydrate Polymers·Leonardo M B FerreiraMaria Palmira D Gremião

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.